CLDX icon

Celldex Therapeutics

102 hedge funds and large institutions have $27.4M invested in Celldex Therapeutics in 2018 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 21 increasing their positions, 37 reducing their positions, and 48 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10:

less ownership

Funds ownership:

less funds holding

Funds holding:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

60% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 48

66% less call options, than puts

Call options by funds: $25K | Put options by funds: $74K

84% less capital invested

Capital invested by funds: $172M → $27.4M (-$145M)

Holders
102
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$25K
Puts
$74K
Net Calls
Net Calls Change

Top Sellers

1 -$17.9M
2 -$13.9M
3 -$3.28M
4
TA
Teachers Advisors
New York
-$2.35M
5
Charles Schwab
Charles Schwab
California
-$1.34M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$28K
52
$27K
53
$24K
54
$23K
55
$22K
56
$19K
57
$18K
58
$18K
59
$15K
60
$14K
61
$14K
62
$13K
63
$12K
64
$11K
65
$10K
66
$8K
67
$8K
68
$7K
69
$6K
70
$6K
71
$6K
72
$6K
73
$6K
74
$5K
75
$5K